Read i bc27f85be50b71b1 Online
Authors: Unknown
complications of, 376
therapy, 344, 860t
in echocardiography, 32-33
Color duplex imaging in vascular evalu
Contllsion
ation, 373t
cerebral, 3071
Colostomy, 548-549, 550
of lung, 140t, 144
10 intestinal obsrruction, 533
in rib fractures, 144. 149
Com., 282, 2821, 755-757, 7561
Coord Ina lion lests. 299, 300t
Glasgow Scale on, 283-284, 2841
Corneal reflex, 2901, 297
in liver disease, 543-544
Coronary arteries, 1 2
Comfort measures in end of life care, 755
anatomy of, 3f
Companment syndrome, 399
angiography of. 38
in casts, 220, 223, 224
angioplasty of, 5 1
INDEX
937
atherosclerosis of, 428
Cruciate ligament repair, arthroscopic
in diabetes mellitus, 684
anterior, 215-216, 218t
directional atherectomy in, 51-52
posterior, 218t
lipid blood levels in, 28-29
Cryoprecipitate, 419t
management of, 51-52
Crystals in urine, 565t
myocardial ischemia in, 40
Culture techniques, 611-612
bypass graft, 52-53
in wounds, 482
spasm of, myocardial ischemia in, 40
Cushing's disease and syndrome, 664-
stem placement in, 52
665
Corpectomy. 21 It
hypertension in, 395t
Corrigan's pulse, 17t
Cyclophosphamide, 855t
Corticospinal traer, 276t
Cyciosporine in organ transplantation,
Corticosteroid therapy, 842t
704t
inhaled, 861 t
Cystecromy, 597
intranasal, 864t
Cystic fibrosis, 133t, 136-137
myopathy in, 759
diagnostic tests in,S t9t-520t
in nausea and vomiting, 846r
Cystitis, 582-583
in organ transplantation, 704r
interstitial,583
Cortisol, 662(, 669-670
Cystography, radionuclidc, 569
deficiency of, 672
Cystometrography, 568
target sites and actions of, 669t
Cysroscopy, 567, 568
Cosynrropin test, 662t
Cytarabine, 856t
Cough
Cytology, 612
antitussives in, 852t
Cytomegalovirus infections, 636-637
enhancement in physical therapy, 153
in HIV infection and AIDS, 635t, 637
examination in respiratory evaluation,
109
Dacarbazine, 855t
in extra pleural disorders, 145t-
Dactinomycin, 855r
147t
Daily living activities
in obstructive disorders, 131 t-134t
in hip arthroplasty, 192
physical therapy based on, 154t
in shoulder arthroplasty, 204
in restrictive disorders, 138t-140r
Dalteparin sodium, 844t
In pertussis, 620
Danaparoid sodium, 844t
Crackles, 103-104
Daunorubicin, 856t
Cranial nerves, 287, 288t-292t
Dead space, respiratory, 127t
disorders in diabetes mellitus, 684t
Debridement of wounds, 485-488
origin and function of, 288t-292t
autolytic, 486
testing of, 288t-292t, 297
enzymatic, 488
Craniectomy, 325, 326
mechanical,486-488
Cranioplasty, 325
nonseleCtive, 485, 486-488
Craniotomy, 325
selective, 485, 486, 488
Cranium, 260
sharp, 486
Creatine kinase levels in cardiac evalua
Decerebration, 296
tion, 29-30, 30t
Decortication, 296
and physical therapy, 31
Decubitus ulcers, 162, 163,470-471
Cre::ninine tests, 564-565
staging and classification of, 483,
after angiography, 370
483t
Critical illness
Defibrillator, automatic implantable carĀ·
myopathy in, 759
diac, 56
polyneuroPalhy in, 758-759
Degenerative disorders of central ner
Crohn's disease. 537-538
vous system, 319-321
938
ACl.ITE CARE HANDBOOK FOR I'HYSICAL THERAPISTS
Delirium, 282r
Dipyridamole, 852t
in intensive care unit, 757-758
in thallium stress tcst, 36
tremens, in alcohol withdrawal, 760
Disc disorders, intervcrtebral, 210-213
Dementia, 282t
artificial disc implantation in, 212-
in HIV infection and AIDS, 635r
213
Demyelination
indications for surgery in, 21 1 t
in Guillain-Barre syndrome, 320
Discecromy, 210, 21 1 t
in multiple sclerosis, 320-321
Discrimination, two-point, 298r
Dermaromes, 274, 280f
Dislocations
in musculoskeletal examination, 163,
of hip, 176-177
164r, 165r
in pelvic fractures, 175f
Dermis
of shoulder, 185
burns of, 449t
Diuretics, 861 t
Structure :md function of, 437, 438(
osmotic, 867t
wounds of, 483, 483r
Diverticular disease, 530-531
Diabetes insipidus, 667-668
Diverticulitis, 530
nephrogenic, 667, 668
Dobbhoff tube, 799t-800t
water deprivation test in, 662t--663t
Dobutamine in stress echocardiography,
Diabetes mellirus, 428, 673-685
32, 33
complications of, 679-685
Donors in transplantation procedures,
foot disorders in, 471-472, 681, 682t
699-701
hypoglycemia in, 677, 685
in bone marrow transplantation, 700,
infections in, 681
733
insulin pump therapy in, 676t
cadaveric donors, 699
kcroacidosis in, 680-681
in kidney rransplanration, 700, 709
kidney disorders in, 572, 580-581,
living donors, 699-700, 701
600
in lung rr:msplamarion, 700, 70 1, 729
neuropathy in, 471-472, 681-684
matching to recipient, 700-70 I
signs and symproms of, 683t--684t
in pancreas transplantation, 700,
types of, 683t-684t
717-718
physical therapy in, 677
Doppler imaging
skin disorders in, 681
in neurologic evaluation, 301-302
ulceration in, 469t, 471-472
in vascular evaluation, 373t
tCSt'S monitoring control of, 675t
Doxorubicin, 856t
rype 1, 674-677
Drainage
rype 2, 674, 677-679
of cerebrospinal fluid, 324r, 798t
vascular disorders in, 684
Jackson-Prarr drains in, 715, 803t
Dialysis
in pancreas transplantation, compariimermincnt hemodialysis, 589-592,
son of cmeric and bladder
590f, 591 f
techniques, 718
peritoneal, 587-588, 589f
poStoperative, 803t
Diaphragm of sella turcica, 269r
active, 803t
Diarrhea, drug therapy in, 863t
in liver transplantation, 715
Diasrole, 6
passive, 803t
blood pressure in, 19, 19t, 393f, 784t,
postural, 897-900
787r
conrraindicarions to, 897, 899
Diencephalon, 260, 265r-266t
typcs of patient positions in, 897,
Diffusion, 587
898f
of oxygen, 770
from wounds, 481-482
Digitalis, 867t
Dressings, 488-489, 490r-492t
toxicity of, 59, 60(, 867t
in burns, 460t, 46 I t